# Arrakis Therapeutics

**Canonical:** https://apis.io/providers/arrakis-therapeutics/  
**Website:** https://www.arrakistx.com  
**APIs profiled:** 0

Arrakis Therapeutics is a clinical-stage biopharmaceutical company pioneering RNA-targeted small molecules (rSMs) — orally available small-molecule medicines designed to bind directly to RNA and reach targets long considered undruggable. Its rSM Platform and rSM Toolkit industrialize the discovery and development of these medicines across proprietary and partnered programs, with a lead candidate addressing the root cause of Type 1 Myotonic Dystrophy (DM1). Based in Waltham, Massachusetts, the company is backed by Canaan Partners. This profile is part of the API Evangelist network; Arrakis Therapeutics does not currently publish a public developer API, SDK, or documentation surface.

## Kin Score — 4.7 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 4.7).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Arrakis Therapeutics Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, RNA, Drug Discovery, Genetic Medicine, Small Molecules, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/arrakis-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.